172 related articles for article (PubMed ID: 1849866)
21. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
[TBL] [Abstract][Full Text] [Related]
22. Relationship between lipoprotein- and oxidation-related variables and atheroma lipid composition in subjects undergoing coronary artery bypass graft surgery.
Craig WY; Rawstron MW; Rundell CA; Robinson E; Poulin SE; Neveux LM; Nishina PM; Keilson LM
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1512-7. PubMed ID: 10364083
[TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
24. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.
Fogelman AM; Shechter I; Seager J; Hokom M; Child JS; Edwards PA
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2214-8. PubMed ID: 6769124
[TBL] [Abstract][Full Text] [Related]
25. Site-specific trapping of reactive species in low-density lipoprotein oxidation: biological implications.
Kalyanaraman B; Joseph J; Parthasarathy S
Biochim Biophys Acta; 1993 Jun; 1168(2):220-7. PubMed ID: 8389205
[TBL] [Abstract][Full Text] [Related]
26. The ESR characterization of molecular mobility in the lipid surface layer of human serum lipoproteins.
Kveder M; Pifat G; Pecar S; Schara M
Chem Phys Lipids; 1994 Mar; 70(1):101-8. PubMed ID: 8013052
[TBL] [Abstract][Full Text] [Related]
27. [Physico-chemical properties of low density lipoproteins isolated in an equilibrium density gradient].
Valentinova NV; Bushueva TL; Medvedeva NV; Morozkin AD; Fuki IV
Mol Biol (Mosk); 1989; 23(5):1447-54. PubMed ID: 2558294
[TBL] [Abstract][Full Text] [Related]
28. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
Napoli C; D'Armiento FP; Mancini FP; Postiglione A; Witztum JL; Palumbo G; Palinski W
J Clin Invest; 1997 Dec; 100(11):2680-90. PubMed ID: 9389731
[TBL] [Abstract][Full Text] [Related]
29. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
Li GX; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
[TBL] [Abstract][Full Text] [Related]
30. [Changes in the surface potential of plasma lipoproteins in ischemic heart disease. Studied with spin probes].
Panasenko OM; Azizova OA; Arnol'd K; Borin ML
Biull Eksp Biol Med; 1986 Jun; 101(6):690-3. PubMed ID: 3015278
[TBL] [Abstract][Full Text] [Related]
31. Significant association of lipid peroxidation products with high density lipoproteins.
Hahn M; Subbiah MT
Biochem Mol Biol Int; 1994 Jul; 33(4):699-704. PubMed ID: 7981657
[TBL] [Abstract][Full Text] [Related]
32. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E.
Prasad K; Kalra J
Am Heart J; 1993 Apr; 125(4):958-73. PubMed ID: 8465768
[TBL] [Abstract][Full Text] [Related]
33. [Characteristics of the structural organization of lipoproteins in the blood plasma of patients with ischemic heart disease using the spin probe method].
Panasenko OM; Azizova OA; Torkhovskaia TI; Dudaev VA
Vopr Med Khim; 1984; 30(6):40-5. PubMed ID: 6098993
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
Johnston TP; Zhou X
J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
[TBL] [Abstract][Full Text] [Related]
35. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
Chiu HC; Jeng JR; Shieh SM
Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
[TBL] [Abstract][Full Text] [Related]
36. The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.
Vlasova II
Platelets; 2000 Nov; 11(7):406-14. PubMed ID: 11132108
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
[TBL] [Abstract][Full Text] [Related]
38. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women.
Mutlu-Türkoğlu U; Oztezcan S; Telci A; Orhan Y; Aykaç-Toker G; Sivas A; Uysal M
Clin Exp Med; 2003 Feb; 2(4):171-4. PubMed ID: 12624707
[TBL] [Abstract][Full Text] [Related]
39. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
Staprans I; Pan XM; Rapp JH; Feingold KR
Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
[TBL] [Abstract][Full Text] [Related]
40. Nitroxide reduction with ascorbic acid in spin labeled human plasma LDL and VLDL.
Kveder M; Pifat G; Pecar S; Schara M; Ramos P; Esterbauer H
Chem Phys Lipids; 1997 Jan; 85(1):1-12. PubMed ID: 9032943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
